Dialysis world news


Vancomycin-resistant MRSA identified in a patient in Brazil. PDF Print
EurekAlert: "This is the first-ever reported bloodstream infection caused by a highly vancomycin-resistant MRSA bacteria," Arias said. "If we lose vancomycin, it would make it very difficult and expensive to treat these infections," he said. Arias and his colleagues conducted microbiological and genetic analyses of an MRSA superbug recovered from the blood of a 35-year-old Brazilian man and identified a novel transferable genetic element (plasmid) that carries the genes necessary for vancomycin resistance (vanA gene cluster).

...

 
Diabetes complication rate in the U.S. shows a sharp decline. PDF Print
NY Times: Federal researchers on Wednesday reported the first broad national picture of progress against some of the most devastating complications of diabetes, which affects millions of Americans, finding that rates of heart attacks, strokes, kidney failure and amputations fell sharply over the past two decades.

...

 
NEJM - New drug regimen cures 90% of patients with hepatitis C and cirrhosis. PDF Print
Eurekalert: Interferon previously was the only agent to show effectiveness against hepatitis C, but patients often relapsed and the therapy caused multiple side effects. The new regimen is interferon-free and consists of several agents — ABT-450/ritonavir, ombitasvir, dasabuvir and ribavirin. Twelve weeks after the last dose, no hepatitis C virus was detected in the bloodstream of 91.8 percent of patients who took the pills for 12 weeks. Among patients treated for 24 weeks, 95.9 percent were virus-free 12 weeks after the end of therapy.

...

 
Chromium supplements of no benefit in lowering blood sugar PDF Print
EurekAlert: A new study by a University of Miami (UM) researcher analyses nearly three decades of data on the effect of chromium supplementation on blood sugar and concludes that chromium supplements are not effective at lowering fasting blood sugar in healthy individuals, or diabetics.

...

 
No ischemic EKG changes plus very low cardiac high-sensitivity troponin T levels rule out MI. PDF Print
JACC: Conclusions. All patients with chest pain who have an initial hs-cTnT level of <5 ng/l and no signs of ischemia on ECG have a minimal risk of MI or death within 30 days and can be safely discharged directly from the ED.

...

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 2406
Share |
Copyright © 2014 Global Dialysis. All Rights Reserved.